Related references
Note: Only part of the references are listed.The physiology of alternative splicing
Luciano E. Marasco et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2023)
The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma
Runzhi Huang et al.
CANCER CONTROL (2022)
Characterization and clustering of kinase isoform expression in metastatic melanoma
David O. Holland et al.
PLOS COMPUTATIONAL BIOLOGY (2022)
Alternative Splicing and Isoforms: From Mechanisms to Diseases
Qi Liu et al.
GENES (2022)
Alternative splicing as a source of phenotypic diversity
Charlotte J. Wright et al.
NATURE REVIEWS GENETICS (2022)
Alternative Splicing in Human Physiology and Disease
Pinelopi I. Artemaki et al.
GENES (2022)
Alternative splicing level related to intron size and organism complexity
Pengcheng Yang et al.
BMC GENOMICS (2021)
DeepLC can predict retention times for peptides that carry as-yet unseen modifications
Robbin Bouwmeester et al.
NATURE METHODS (2021)
New insights into molecular changes in skeletal muscle aging and disease: Differential alternative splicing and senescence
Elizaveta M. Solovyeva et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2021)
A Transcriptome-Wide Isoform Landscape of Melanocytic Nevi and Primary Melanomas Identifies Gene Isoforms Associated with Malignancy
Siras Hakobyan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM)
Shuguang Zhang et al.
JOURNAL OF IMMUNOTHERAPY (2021)
Roles and mechanisms of alternative splicing in cancer - implications for care
Sophie C. Bonnal et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
An analysis of tissue-specific alternative splicing at the protein level
Jose Manuel Rodriguez et al.
PLOS COMPUTATIONAL BIOLOGY (2020)
Aberrant RNA Splicing Events Driven by Mutations of RNA-Binding Proteins as Indicators for Skin Cutaneous Melanoma Prognosis
Chao Mei et al.
FRONTIERS IN ONCOLOGY (2020)
Resolving genetic heterogeneity in cancer
Samra Turajlic et al.
NATURE REVIEWS GENETICS (2019)
Comment on A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands
Zach Rolfs et al.
SCIENCE IMMUNOLOGY (2019)
Response to Comment on A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands
Pouya Faridi et al.
SCIENCE IMMUNOLOGY (2019)
GENCODE reference annotation for the human and mouse genomes
Adam Frankish et al.
NUCLEIC ACIDS RESEARCH (2019)
Splice-Junction-Based Mapping of Alternative Isoforms in the Human Proteome
Edward Lau Yu Han et al.
CELL REPORTS (2019)
Detection of Proteome Diversity Resulted from Alternative Splicing is Limited by Trypsin Cleavage Specificity
Xiaojing Wang et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Proteogenomics of Malignant Melanoma Cell Lines: The Effect of Stringency of Exome Data Filtering on Variant Peptide Identification in Shotgun Proteomics
Anna A. Lobas et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Alternative splicing isoforms in health and disease
Hyoung Kyu Kim et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2018)
A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands
Pouya Faridi et al.
SCIENCE IMMUNOLOGY (2018)
The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer
Ettaib El Marabti et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
Alternative splicing and the evolution of phenotypic novelty
Stephen J. Bush et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component
Xujun Liu et al.
MOLECULAR CANCER (2017)
MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics
Andy T. Kong et al.
NATURE METHODS (2017)
The Relationship between Alternative Splicing and Proteomic Complexity
Benjamin J. Blencowe
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Alternative Splicing May Not Be the Key to Proteome Complexity
Michael L. Tress et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Impact of Alternative Splicing on the Human Proteome
Yansheng Liu et al.
CELL REPORTS (2017)
Melanosomal formation of PMEL core amyloid is driven by aromatic residues
Jia Shee Hee et al.
SCIENTIFIC REPORTS (2017)
RNA mis-splicing in disease
Marina M. Scotti et al.
NATURE REVIEWS GENETICS (2016)
Predictive chromatography of peptides and proteins as a complementary tool for proteomics
Irina A. Tarasova et al.
ANALYST (2016)
Defective control of pre-messenger RNA splicing in human disease
Benoit Chabot et al.
JOURNAL OF CELL BIOLOGY (2016)
Six alternative proteases for mass spectrometry-based proteomics beyond trypsin
Piero Giansanti et al.
NATURE PROTOCOLS (2016)
CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation
P. Zhang et al.
ONCOGENE (2016)
Mass spectrometrists should search only for peptides they care about
William Stafford Noble
NATURE METHODS (2015)
Apolipoprotein E Regulates Amyloid Formation within Endosomes of Pigment Cells
Guillaume van Niel et al.
CELL REPORTS (2015)
Alternatively Spliced Homologous Exons Have Ancient Origins and Are Highly Expressed at the Protein Level
Federico Abascal et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
MS2PIP: a tool for MS/MS peak intensity prediction
Sven Degroeve et al.
BIOINFORMATICS (2013)
SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
Simon J. Furney et al.
CANCER DISCOVERY (2013)
Unipro UGENE: a unified bioinformatics toolkit
Konstantin Okonechnikov et al.
BIOINFORMATICS (2012)
Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction
Jian Ye et al.
BMC BIOINFORMATICS (2012)
Tissue-Specific Splicing of Disordered Segments that Embed Binding Motifs Rewires Protein Interaction Networks
Marija Buljan et al.
MOLECULAR CELL (2012)
Expansion of the eukaryotic proteome by alternative splicing
Timothy W. Nilsen et al.
NATURE (2010)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
Qun Pan et al.
NATURE GENETICS (2008)
Cancer/testis genes expression in human melanoma cell lines
Irina N. Mikhaylova et al.
MELANOMA RESEARCH (2008)
Proteomics studies confirm the presence of alternative protein isoforms on a large scale
Michael L. Tress et al.
GENOME BIOLOGY (2008)
Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry
Joshua E. Elias et al.
NATURE METHODS (2007)
Variation in alternative splicing across human tissues
G Yeo et al.
GENOME BIOLOGY (2004)
Pmel17 initiates premelanosome morphogenesis within multivesicular bodies
JF Berson et al.
MOLECULAR BIOLOGY OF THE CELL (2001)